Clinical Trial Results: A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma [Phase 2]

View source ↗

Summary

Phase II, single-arm trial evaluating RAD001 (everolimus) with letrozole and metformin in advanced or recurrent endometrial carcinoma; results posted after comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Letrozole (letrozole)
• RAD001 (Everolimus) (everolimus)
• metformin (metformin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2026-07-30